Articles tagged "Renal failure"

2022 American Transplant Congress
Renal Function After Orthotopic Liver Transplantation
N. Kemmer¹, z. Alam², S. Desai³, L. Grater⁴, K. Robichaux⁵, S. Mohammed⁵, M. Gosselin⁴, A. Kumar⁶, J. Buggs⁷
¹Transplant Hepatology, Tampa General Hospital, Tampa, FL, ²Lake Erie College of Osteopathic Medicine, Bradenton, FL, ³Western University of Osteopathic Medicine, Pomona, CA, ⁴University of Tampa, Tampa, FL, ⁵University of South Florida, Tampa, FL, ⁶Morsani College of Medicine, University of South Florida, Tampa, FL, ⁷Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Patients with end-stage liver disease are susceptible to renal dysfunction especially during liver transplantation (LTX). Continuous renal replacement therapy (CRRT) can be used to…
2022 American Transplant Congress
Holes in the Safety-Net: Examining the Path to Kidney Transplantation for Liver Transplant Recipients with Persistent Kidney Dysfunction
A. J. Erhardt, M. J. Hobeika, T. Menser, A. Saharia, O. Okidi, C. Mobley, R. McMillan, L. W. Moore, H. Podder, S. Yi, R. J. Knight, A. Gaber, R. Ghobrial
Department of Surgery; J.C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX
*Purpose: The 2017 combined liver-kidney allocation modification provided early access to kidney transplantation (KT) for liver transplant (LT) recipients with severe post-LT kidney dysfunction. Although…
2022 American Transplant Congress
Clinical Relevance of Absolute BK Polyoma Viral Load Kinetics in Patients with Biopsy Proven BK Polyomavirus Associated Nephropathy
H. Omic¹, J. P. Kläger¹, H. Herkner¹, S. W. Aberle¹, H. Regele¹, L. Weseslindtner¹, T. A. Schrag¹, G. Bond¹, K. Hohenstein¹, B. Watschinger¹, J. Werzowa², R. Strassl¹, M. Eder¹, Z. Kikic¹
¹Medical University of Vienna, Vienna, Austria, ²Ludwig Boltzmann Institute of Osteology at the Hanusch Hospital of WGKK and AUVA Trauma Centre Meidling, 1st Medical Department, Hanusch Hospital, Vienna, Austria
*Purpose: The absolute BK viral load is an important diagnostic surrogate for BK polyomavirus associated nephropathy (PyVAN) after renal transplant (KTX) and serial assessment of…
2022 American Transplant Congress
Risk of Tumor Recurrence, Functional Decline, and Metastatic Disease of Renal Transplant in Recipients with Hereditary Kidney Cancer: A Case Series
M. Antony, A. Chaurasia, N. Gopal, Z. Kozel, M. Linehan, M. Ball
Urologic Oncology Branch, National Cancer Institute, Bethesda, MD
*Purpose: Von Hippel-Lindau disease is a hereditary cancer syndrome characterized by bilateral, multifocal renal tumors and cysts. Advancements in nephron-sparing surgeries have improved functional and…
2022 American Transplant Congress
Prediction Model of Post-Donation Renal Function Using Dynamic Kidney CT Volumetry in Living Donor
S. Lim¹, J. Kwon², Y. Ko¹, H. Kwon¹, J. Jung¹, H. Kwon¹, Y. Kim¹, J. Park², K. Lee², S. Shin¹
¹Asan Medical Center, Seoul, Songpa, Korea, Republic of, ²Samsung Medical Center, Seoul, Gangnam, Korea, Republic of
*Purpose: The risk of renal failure after live kidney donation can be predicted based on various clinical information. We tried introduce a model to predict…
2022 American Transplant Congress
Revolutionizing Clinical Diagnostic Models for Acute Rejection Using Generative Adversarial Networks
W. Yazar¹, R. Nijor¹, R. Sarwal¹, N. Titzler¹, M. Sarwal², S. Ghosh¹
¹Nephrosant, Brisbane, CA, ²NephroSant, Brisbane, CA
*Purpose: Data heterogeneity, incompleteness and class-imbalance, hallmarks of real world healthcare data (RWHD), pose long-standing challenges to the accuracy of AI-based models. This research evaluates…
2022 American Transplant Congress
Meta-Analysis of the Chronic Exposure to Calcineurin Inhibitors and the Risk for Chronic and End-Stage Kidney Disease in Non-Renal Solid Organ Transplant Recipients
A. Alvarez Elias¹, M. Riedl¹, D. Stewart², A. Ruco³, P. Bobos³, S. Maharaj⁴, V. Shah⁵, E. Uleryk⁶, C. Teoh¹, R. Parekh¹
¹Hospital for Sick Children, Toronto, ON, Canada, ²Royal Hospital for Children, Glasgow, United Kingdom, ³St. Michael’s Hospital, Toronto, ON, Canada, ⁴University of Toronto, Toronto, ON, Canada, ⁵Mount Sinai Hospital, Toronto, ON, Canada, ⁶E. M. Uleryk Consulting, Toronto, ON, Canada
*Purpose: Calcineurin inhibitors (CNI) are standard of care immunosuppressants among all solid organ transplant (SOT) recipients, and the most common side effect is nephrotoxicity. There…
2022 American Transplant Congress
Dynapenia Among Kidney Transplant Candidates and Recipients in the United States
A. S. Nalatwad¹, X. Chen¹, N. M. Chu¹, S. P. Norman², D. L. Segev¹, M. McAdams-Demarco¹
¹Epidemiology Research Group in Organ Transplantation, Johns Hopkins University School of Medicine, Baltimore, MD, ²Univ of Michigan Medical Ctr, Ann Arbor, MI
*Purpose: Among Kidney Transplant (KT) patients, sarcopenia, loss of muscle mass, is prevalent and has been associated with post-KT mortality. The burden of dynapenia, an…
2022 American Transplant Congress
Association of Native Kidney Disease with De Novo Cancer Development After Kidney Transplant
Y. Caliskan¹, D. Axelrod², R. Li¹, W. Cheungpasitporn³, M. Schnitzler¹, M. McAdams DeMarco⁴, J. Ahn⁴, T. Alhamad⁵, H. Randall¹, S. Bae⁴, D. Segev⁴, K. L. Lentine¹
¹Saint Louis University, Saint Louis, MO, ²University of Iowa, Iowa City, IA, ³Mayo Clinic, Rochester, MN, ⁴John Hopkins University, Baltimore, MD, ⁵Washington University in Saint Louis, Saint Louis, MO
*Purpose: Primary glomerulonephritis (GN) and congenital anomalies of the kidney and urinary tract (CAKUT) have been shown to be associated with cancer development in the…
2022 American Transplant Congress
25-Year Risk of ESRD Among Living Kidney Donors
J. Wainright¹, A. Robinson¹, A. Wilk¹, D. Klassen², W. Cherikh¹, D. Stewart¹
¹Research, UNOS, Richmond, VA, ²Office of the Chief Medical Officer, UNOS, Richmond, VA
*Purpose: Previous research on post-donation ESRD in living kidney donors (LKDs) has been limited by short follow-up time, the small number of ESRD cases available…

1
2
3
…
15
Next Page »